Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $6.7100 (10.54%) ($5.6000 - $7.4900) on Tue. Aug. 11, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 8.65% (three month average) | RSI | 60 | Latest Price | $6.7100(10.54%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -3.7% a day on average for past five trading days. | Weekly Trend | CAPR declines -5.6% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) IGOV(27%) BWX(18%) TLT(23%) CEMB(16%) VCIT(16%) | Factors Impacting CAPR price | CAPR will decline at least -4.325% in a week (0% probabilities). XLB(-30%) URA(-29%) PAVE(-27%) XOP(-24%) XLI(-24%) | | | | | Relative Volatility | | | | Market Trend Strength | -4.325% (StdDev 8.65%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | Resistance Level | $7.17 | 5 Day Moving Average | $7.08(-5.23%) | 10 Day Moving Average | $7.55(-11.13%) | 20 Day Moving Average | $7.17(-6.42%) | To recent high | -31.6% | To recent low | 33.9% | Market Cap | $132m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |